Article révisé par les pairs
Titre:
  • Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial.
Auteur:Abdel Azim, Hatem Hamdy; Rothé, Françoise; Aura, Claudia Monica; Bavington, Malcolm; Maetens, Marion M.; Rouas, Ghizlane; Gebhart, Géraldine; Gamez, Cristina; Eidtmann, Holger; Baselga, José; Piccart-Gebhart, Martine; Ellis, Catherine; Vuylsteke, Peter; Cure, Hervé; Domont, Julien; Ferro, Antonella; Toral-Peña, Juan Carlos; de Azambuja, Evandro; Sotiriou, Christos; Di Cosimo, Serena; Ignatiadis, Michail
Informations sur la publication:Breast, 22, 6, page (1060-1065)
Statut de publication:Publié, 2013-12
Sujet CREF:Sciences biomédicales
Cancérologie
Médecine pathologie humaine
MeSH keywords:Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- chemistry -- drug therapy -- pathology
Chemotherapy, Adjuvant
Female
Humans
Middle Aged
Molecular Targeted Therapy
Neoadjuvant Therapy
Neoplastic Cells, Circulating -- chemistry -- pathology
Paclitaxel -- administration & dosage
Quinazolines -- administration & dosage
Receptor, ErbB-2 -- analysis -- antagonists & inhibitors
Young Adult
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/j.breast.2013.08.014
info:pii/S0960-9776(13)00248-8
info:scp/84887201080
info:pmid/24060577

Documents en relation

DI-fusion